Skin disorders
22 results
Applied filters
Preparing to use ustekinumab biosimilar
31 July 2026Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
The licence and supporting evidence for ustekinumab biosimilars
31 July 2026Ustekinumab biosimilars are available for use within the NHS. Learn about indications, formulations, supporting evidence and differences.
Permethrin for scabies
21 July 2026SPS PGD template for supply of permethrin for the treatment of scabies in specified patient groups.
Malathion for scabies
21 July 2026SPS PGD template for supply of malathion for the treatment of scabies in specified patient groups.
The licence and supporting evidence for omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
Preparing to use omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice.
Flucloxacillin for infected insect bites or stings
28 April 2026SPS PGD template for supply of flucloxacillin for infected insect bites or stings.
Clarithromycin for infected insect bites or stings
28 April 2026SPS PGD template for supply of clarithromycin for infected insect bites or stings in penicillin allergy.
Erythromycin for infected insect bites or stings
28 April 2026SPS PGD template for supply of erythromycin for infected insect bites or stings in both penicillin allergy and pregnancy.
Hydrogen peroxide 1% cream for impetigo
8 April 2026SPS protocol template (registered pharmacists and in a registered pharmacy) and PGD template for the supply of hydrogen peroxide 1% cream for localised impetigo